Related Experiment Videos

Efficacy of CAPD as the primary treatment for end-stage renal failure in children

M Barakat1, J M Savage, A Burns

  • 1Department of Child Health, Queen's University of Belfast, UK.

Child Nephrology and Urology
|January 1, 1992
PubMed

Insights

Continuous ambulatory peritoneal dialysis (CAPD) is a viable first option for childhood end-stage renal failure (ESRF) when hemodialysis is unavailable. This study found no deaths and manageable complications in children treated with CAPD.

Area of Science:

  • Pediatric Nephrology
  • Renal Replacement Therapy

Background:

  • End-stage renal failure (ESRF) in children presents unique challenges.
  • Continuous ambulatory peritoneal dialysis (CAPD) has been the primary treatment modality for pediatric ESRF in Northern Ireland for six years.
  • Evaluating the efficacy and safety of CAPD in this pediatric population is crucial.

Purpose of the Study:

  • To assess the outcomes of children with ESRF treated with CAPD.
  • To identify complications associated with CAPD in pediatric patients.
  • To determine the suitability of home CAPD as a first-line treatment for childhood ESRF.

Main Methods:

  • Retrospective analysis of 22 children with ESRF treated with CAPD over a six-year period.
  • Data collection on treatment outcomes, complications, and patient demographics.
  • Comparison with renal transplant data where applicable.

Main Results:

  • No deaths occurred among the 22 CAPD-treated patients.
  • The incidence of peritonitis was one episode per 11.6 patient treatment months.
  • Complications included peritonitis (requiring catheter replacement in 3 patients), exit site infections, hernia, and hydrothorax.
  • Peritonitis, undernutrition, growth retardation, and developmental delay were more prevalent in children under two years of age.

Conclusions:

  • Home CAPD is a recommended and viable first-line treatment for pediatric ESRF, especially when hemodialysis facilities are not readily accessible.
  • Careful monitoring is essential to manage complications, particularly in younger children.
  • CAPD offers a life-sustaining treatment option with no mortality in this cohort.

Related Concept Videos